Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
2.930
-0.050 (-1.68%)
Nov 21, 2024, 4:00 PM EST - Market closed
Firefly Neuroscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -7.75 | -2.6 | -3.9 | -4.38 |
| Depreciation & Amortization | 0.01 | - | 0.01 | 0.43 |
| Loss (Gain) From Sale of Assets | - | - | -0.09 | -0.31 |
| Loss (Gain) From Sale of Investments | - | - | - | -0.55 |
| Stock-Based Compensation | 2.5 | 0.3 | 0.06 | 0.61 |
| Other Operating Activities | 0.21 | - | 0.52 | 0.58 |
| Change in Accounts Receivable | -0.18 | -0.07 | 0.03 | 0.04 |
| Change in Accounts Payable | 0.6 | 0.04 | -0.08 | 0.21 |
| Change in Unearned Revenue | -0.46 | -0.91 | 0.45 | -0.37 |
| Change in Other Net Operating Assets | -0.37 | 1.08 | 0.11 | -0.07 |
| Operating Cash Flow | -5.45 | -2.17 | -2.89 | -3.82 |
| Sale of Property, Plant & Equipment | - | - | 0.26 | 0.6 |
| Sale (Purchase) of Intangibles | -0.79 | -0.39 | - | - |
| Investment in Securities | - | - | - | 1 |
| Investing Cash Flow | -0.79 | -0.39 | 0.26 | 1.6 |
| Short-Term Debt Issued | - | - | 1.75 | 2.04 |
| Total Debt Issued | - | - | 1.75 | 2.04 |
| Net Debt Issued (Repaid) | - | - | 1.75 | 2.04 |
| Issuance of Common Stock | 8.12 | 4.64 | 0.29 | - |
| Financing Cash Flow | 6.57 | 4.64 | 2.04 | 2.04 |
| Net Cash Flow | 0.34 | 2.09 | -0.6 | -0.18 |
| Free Cash Flow | -5.52 | -2.17 | -2.89 | -3.82 |
| Free Cash Flow Margin | -7452.70% | -436.14% | - | -11937.50% |
| Free Cash Flow Per Share | -0.17 | -0.07 | -2.10 | - |
| Levered Free Cash Flow | -6.27 | -1.94 | -1.81 | - |
| Unlevered Free Cash Flow | -6.26 | -1.93 | -1.53 | - |
| Change in Net Working Capital | 0.58 | -0.09 | -0.5 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.